Performs commissioned manufacturing of amino acids, pharmaceutical products in bulk and pharmaceutical intermediates, and develops, manufactures and sales pharmaceutical plasters. Pharmaceuticals & Fine Chemicals Business of SEKISUI MEDICAL.

To Previous Page

History of Fine Chemical Business

*Our Pharmaceuticals & Fine Chemicals Business inherited the chemicals business operated by our former company Daiichi Pure Chemicals.

1947 Daiichi Pure Chemicals Co., Ltd. was founded on July 10th.
Production of "Hydrosulfite", "Lactic acid", and "Ethyl Lactate" at Yanagishima Plant started.
1948 Production of diagnostic reagent "Sulfosalicylic acid" started.
1953 Production of metal chelating reagent "ZONON®" started.
1954 Production of active pharmaceutical ingredient "p-Aminosalicylic acid" started.
1958 Marketing of amino acid started. Patent for manufacturing amino acids was obtained.
1960 Construction of Funabori Factory was completed.
1969 Production of "L-DOPA" started.
1973 Property in Hachimantai city, Iwate prefecture (used to be called Matsuo-village) was acquired.
1977 Pollution prevention agreement with Hachimantai city, Iwate prefecture (used to be called Matsuo-village) was disclosed.
1978 Construction of Iwate Plant (stage 1) was completed.
Dowa Kasei Kogyo was acquired.
1979 Iwate Plant started operation.
1981 Construction of Iwate Plant (stage 2) was completed.
1984 Iwate Plant was inspected by FDA for the first time.
1985 Funabori Plant was closed and production was integrated into Iwate Plant.
Construction of Iwate Plant (stage 3) was completed.
1992 Construction of anaerobic wastewater treatment plant at Iwate factory was completed.
1994 "Constitution of Quality's Warranty" by Daiichi Pure Chemical was established.
2000 Construction of Iwate Plant (stage 4) was completed.
2001 "ISO14001" certificate was obtained at Iwate Plant.
2004 "ISO14001" certificate of Iwate Plant was renewed.
2006 Construction of Iwate Plant (stage 5) was completed.
2007 "ISO14001" certificate of Iwate Plant was renewed.
2008 Company name change from Daiichi Pure Chemicals Co., Ltd. to Sekisui Medical Co., Ltd.
Inspection by the EDQM(EU)
2011 Enhancement of Peptide Medical Business(Sekisui Medical and JITSUBO sign a joint development contract.)
9th inspection by the FDA(October)
 
To Previous Page